SHERIDAN, WYOMING – November 15, 2024 – Taiwan has emerged as a major player in the global medical technology sector, showcasing its latest innovations at MEDICA 2024, the world's leading medical trade fair held in Düsseldorf, Germany. With a strong focus on artificial intelligence (AI) and surgical applications, Taiwanese companies are revolutionizing healthcare with cutting-edge solutions.
Taiwan's Growing Presence at MEDICA
Taiwan's participation at MEDICA 2024 has reached an all-time high, with over 300 Taiwanese enterprises exhibiting their latest advancements. This significant presence underscores Taiwan's growing influence in the global medical technology market.
A Hub of Innovation
Taiwan's robust technology ecosystem, extensive healthcare data, and strong government support have fueled its rise as a key innovator in the medical sector. The country is particularly renowned for its advancements in precision medicine, combining AI with manufacturing expertise to develop groundbreaking solutions.
Taiwan Excellence Pavilion
The Taiwan Excellence pavilion at MEDICA 2024 showcased 28 innovative products from 17 award-winning companies. These products highlight Taiwan's focus on intelligent medical solutions and surgical applications, demonstrating the country's commitment to advancing healthcare through AI-driven technologies.
AI-Powered Surgeons: The Best Made in Taiwan
At a press conference titled "AI-Powered Surgeons: The Best Made in Taiwan," four leading Taiwanese companies presented their groundbreaking products.
Brain Navi Biotechnology
Gokhan Zorlubas, Business Development Manager at Brain Navi Biotechnology, introduced an AI-powered surgical system designed to enhance surgical accuracy and improve patient outcomes. "Our company is a leader in surgical robotics in Taiwan, focusing on neurosurgery solutions that enhance precision and safety," Zorlubas remarked.
Microbase Technology Corporation
Vanessa Wu, Product Marketing Manager at Microbase Technology Corporation, showcased the LoyalCare nebulization system, a revolutionary innovation in airway care. "MicroBase specializes in technologies such as jet plates, microneedles for drug delivery, and micro-nebulization for inhaled medications. We are also developing AI-powered respiratory stimulation to improve treatment efficacy," Wu explained.
Aplus Biotechnology
Robers Luo, Marketing Manager at Aplus Biotechnology, presented a 3D-printed guide plate for osteotomies, designed to personalize orthopedic procedures. "At Aplus, we develop medical devices with a focus on bone materials, collaborating closely with medical professionals. Our goal is to expand globally to help patients worldwide," Luo shared.
EndoSemio
Chin Shook Leng, Manager at EndoSemio, demonstrated a wireless endoscope tracheotomy kit for minimally invasive procedures. "Our company specializes in image-guided endoscopes and biocompatible tubing. We also offer respiratory catheters for neonatal care and flexible ureteroscopes for urological procedures," Leng said.
Taiwan's Vision for the Future of Healthcare
TAITRA Chairman James C. F. Huang highlighted Taiwan's strong economic growth and notable progress in medical technology at the Taiwan Excellence press conference. "Taiwan is home to industry pioneers leading advancements in artificial intelligence. By combining AI with our manufacturing expertise, we're generating unparalleled innovations in healthcare, particularly in precision medicine and advanced diagnostics," Huang stated.
Taiwan's participation at MEDICA 2024 showcased its dedication to advancing healthcare through AI-driven applications and high-precision engineering. The country's innovative medical technology companies are making significant contributions to the global healthcare landscape, improving patient outcomes, and shaping the future of medicine.